Medite Cancer Diagnostics, Inc. (MDIT)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2017 | 2016 | 2015 |
|---|---|---|---|
| Operating Cash Flow | -2.58 Million | -1.09 Million | -388 Thousand |
| Net Income | -6.81 Million | -2.16 Million | -859 Thousand |
| Depreciation & Amortization | 293 Thousand | 214 Thousand | -177 Thousand |
| Deferred income taxes | 492 Thousand | - | 78 Thousand |
| Stock-based compensation | - | - | - |
| Change in working capital | 1.88 Million | 129 Thousand | 216 Thousand |
| Other non-cash items | 191 Thousand | 1.12 Million | - |
| Investing Cash Flow | -134 Thousand | -115 Thousand | -354 Thousand |
| Investments in PPE | -134 Thousand | -115 Thousand | -354 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | 3.88 Million | 700 Thousand | 1.71 Million |
| Debt repayment | -1.53 Million | -294 Thousand | -342 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 2.34 Million | 406 Thousand | 2.05 Million |
| Other Financing Activities | - | - | - |
| Accounts receivables | 589 Thousand | 314 Thousand | 193 Thousand |
| Accounts payables | -75 Thousand | 557 Thousand | -285 Thousand |
| Inventory | 1.43 Million | -841 Thousand | 340 Thousand |
| Other working capital | -60 Thousand | 99 Thousand | -32 Thousand |
| Cash at beginning of period | 108 Thousand | 614 Thousand | - |
| Cash at end of period | 490 Thousand | 108 Thousand | 970 Thousand |
| Capital Expenditure | -134 Thousand | -115 Thousand | -354 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 382 Thousand | -506 Thousand | 970 Thousand |
| Free Cash Flow | -2.71 Million | -1.2 Million | -742 Thousand |
| Breakdown | 2017 FY | 2016 FY | 2015 FY |
|---|---|---|---|
| Operating Cash Flow | - | - | - |
| Net Income | -6.81 Million | -2.16 Million | -859 Thousand |
| Depreciation & Amortization | 293 Thousand | 214 Thousand | -177 Thousand |
| Deferred income taxes | 492 Thousand | - | 78 Thousand |
| Stock-based compensation | - | - | - |
| Change in working capital | 1.88 Million | 129 Thousand | 216 Thousand |
| Other non-cash items | 191 Thousand | 1.12 Million | - |
| Investing Cash Flow | -134 Thousand | -115 Thousand | -354 Thousand |
| Investments in PPE | -134 Thousand | -115 Thousand | -354 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | 3.88 Million | 700 Thousand | 1.71 Million |
| Debt repayment | -1.53 Million | -294 Thousand | -342 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 2.34 Million | 406 Thousand | 2.05 Million |
| Other Financing Activities | - | - | - |
| Accounts receivables | 589 Thousand | 314 Thousand | 193 Thousand |
| Accounts payables | -75 Thousand | 557 Thousand | -285 Thousand |
| Inventory | 1.43 Million | -841 Thousand | 340 Thousand |
| Other working capital | -60 Thousand | 99 Thousand | -32 Thousand |
| Cash at beginning of period | 108 Thousand | 614 Thousand | - |
| Cash at end of period | 490 Thousand | 108 Thousand | 970 Thousand |
| Capital Expenditure | -134 Thousand | -115 Thousand | -354 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 382 Thousand | -506 Thousand | 970 Thousand |
| Free Cash Flow | -2.71 Million | -1.2 Million | -742 Thousand |
INVU
EAT
LINK
7111
6777
SGYI